Optimizing antimicrobial routes: risk factor analysis for intravenous therapy in children with preseptal orbital cellulitis
Abstract Background The optimal route of antimicrobial administration for preseptal orbital cellulitis (OC) in children remains uncertain. While mild cases may be managed with oral therapy, distinguishing between mild and severe presentations is challenging. The recently proposed ASSET score offers...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-06-01
|
| Series: | Italian Journal of Pediatrics |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13052-025-01931-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849685921401667584 |
|---|---|
| author | Roberto Privato Emanuela Inserra Francesco Pezzoli Alessia Nucci Stefano Masi Elena Chiappini Giuseppe Indolfi Sandra Trapani Luisa Galli Elisabetta Venturini |
| author_facet | Roberto Privato Emanuela Inserra Francesco Pezzoli Alessia Nucci Stefano Masi Elena Chiappini Giuseppe Indolfi Sandra Trapani Luisa Galli Elisabetta Venturini |
| author_sort | Roberto Privato |
| collection | DOAJ |
| description | Abstract Background The optimal route of antimicrobial administration for preseptal orbital cellulitis (OC) in children remains uncertain. While mild cases may be managed with oral therapy, distinguishing between mild and severe presentations is challenging. The recently proposed ASSET score offers a tool for assessing the severity of skin and soft tissue infections, but prospective validation in large cohorts of preseptal OC is lacking. As a result, most patients with periorbital infections are admitted for intravenous (IV) antibiotics. This study aims to identify clinical and laboratory features predictive of severe preseptal OC requiring IV treatment. Methods A retrospective study was conducted at Meyer Children’s Hospital IRCCS, Florence, reviewing outpatient records for OC cases from January 2017 to June 2024. Data on age, sex, clinical presentation, blood tests, and management were collected. Results Previously initiated oral therapy was associated with the need for IV therapy (p < 0.001), as well as the presence of fever (p < 0.001), and severe eyelid swelling (p < 0.001). The median ASSET score was higher in patients with preseptal OC requiring IV therapy (p < 0.001). Differences in laboratory findings were noted between children with preseptal OC managed with and without IV antibiotics. Conclusions Previous trials of oral antibiotics, systemic features, and severe swelling influence clinicians’ decisions to initiate IV antibiotics in preseptal OC. If validated for preseptal OC, the application of the ASSET score could significantly reduce the number of children treated with IV antibiotics. Ancillary blood tests may be useful for detecting preseptal OC requiring IV treatment. |
| format | Article |
| id | doaj-art-906de1befa2e4e2f9a0200da18594d82 |
| institution | DOAJ |
| issn | 1824-7288 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | BMC |
| record_format | Article |
| series | Italian Journal of Pediatrics |
| spelling | doaj-art-906de1befa2e4e2f9a0200da18594d822025-08-20T03:22:54ZengBMCItalian Journal of Pediatrics1824-72882025-06-015111610.1186/s13052-025-01931-xOptimizing antimicrobial routes: risk factor analysis for intravenous therapy in children with preseptal orbital cellulitisRoberto Privato0Emanuela Inserra1Francesco Pezzoli2Alessia Nucci3Stefano Masi4Elena Chiappini5Giuseppe Indolfi6Sandra Trapani7Luisa Galli8Elisabetta Venturini9Department of Health Sciences, University of FlorencePediatric Emergency Department, Meyer Children’s Hospital IRCCSDepartment of Health Sciences, University of FlorencePediatric Emergency Department, Meyer Children’s Hospital IRCCSPediatric Emergency Department, Meyer Children’s Hospital IRCCSDepartment of Health Sciences, University of FlorencePediatric Unit, Meyer Children’s Hospital IRCCSDepartment of Health Sciences, University of FlorenceDepartment of Health Sciences, University of FlorencePaediatric Infectious Diseases Unit, Meyer Children’s Hospital IRCCSAbstract Background The optimal route of antimicrobial administration for preseptal orbital cellulitis (OC) in children remains uncertain. While mild cases may be managed with oral therapy, distinguishing between mild and severe presentations is challenging. The recently proposed ASSET score offers a tool for assessing the severity of skin and soft tissue infections, but prospective validation in large cohorts of preseptal OC is lacking. As a result, most patients with periorbital infections are admitted for intravenous (IV) antibiotics. This study aims to identify clinical and laboratory features predictive of severe preseptal OC requiring IV treatment. Methods A retrospective study was conducted at Meyer Children’s Hospital IRCCS, Florence, reviewing outpatient records for OC cases from January 2017 to June 2024. Data on age, sex, clinical presentation, blood tests, and management were collected. Results Previously initiated oral therapy was associated with the need for IV therapy (p < 0.001), as well as the presence of fever (p < 0.001), and severe eyelid swelling (p < 0.001). The median ASSET score was higher in patients with preseptal OC requiring IV therapy (p < 0.001). Differences in laboratory findings were noted between children with preseptal OC managed with and without IV antibiotics. Conclusions Previous trials of oral antibiotics, systemic features, and severe swelling influence clinicians’ decisions to initiate IV antibiotics in preseptal OC. If validated for preseptal OC, the application of the ASSET score could significantly reduce the number of children treated with IV antibiotics. Ancillary blood tests may be useful for detecting preseptal OC requiring IV treatment.https://doi.org/10.1186/s13052-025-01931-xAntimicrobial routeASSET scoreCellulitisChildren |
| spellingShingle | Roberto Privato Emanuela Inserra Francesco Pezzoli Alessia Nucci Stefano Masi Elena Chiappini Giuseppe Indolfi Sandra Trapani Luisa Galli Elisabetta Venturini Optimizing antimicrobial routes: risk factor analysis for intravenous therapy in children with preseptal orbital cellulitis Italian Journal of Pediatrics Antimicrobial route ASSET score Cellulitis Children |
| title | Optimizing antimicrobial routes: risk factor analysis for intravenous therapy in children with preseptal orbital cellulitis |
| title_full | Optimizing antimicrobial routes: risk factor analysis for intravenous therapy in children with preseptal orbital cellulitis |
| title_fullStr | Optimizing antimicrobial routes: risk factor analysis for intravenous therapy in children with preseptal orbital cellulitis |
| title_full_unstemmed | Optimizing antimicrobial routes: risk factor analysis for intravenous therapy in children with preseptal orbital cellulitis |
| title_short | Optimizing antimicrobial routes: risk factor analysis for intravenous therapy in children with preseptal orbital cellulitis |
| title_sort | optimizing antimicrobial routes risk factor analysis for intravenous therapy in children with preseptal orbital cellulitis |
| topic | Antimicrobial route ASSET score Cellulitis Children |
| url | https://doi.org/10.1186/s13052-025-01931-x |
| work_keys_str_mv | AT robertoprivato optimizingantimicrobialroutesriskfactoranalysisforintravenoustherapyinchildrenwithpreseptalorbitalcellulitis AT emanuelainserra optimizingantimicrobialroutesriskfactoranalysisforintravenoustherapyinchildrenwithpreseptalorbitalcellulitis AT francescopezzoli optimizingantimicrobialroutesriskfactoranalysisforintravenoustherapyinchildrenwithpreseptalorbitalcellulitis AT alessianucci optimizingantimicrobialroutesriskfactoranalysisforintravenoustherapyinchildrenwithpreseptalorbitalcellulitis AT stefanomasi optimizingantimicrobialroutesriskfactoranalysisforintravenoustherapyinchildrenwithpreseptalorbitalcellulitis AT elenachiappini optimizingantimicrobialroutesriskfactoranalysisforintravenoustherapyinchildrenwithpreseptalorbitalcellulitis AT giuseppeindolfi optimizingantimicrobialroutesriskfactoranalysisforintravenoustherapyinchildrenwithpreseptalorbitalcellulitis AT sandratrapani optimizingantimicrobialroutesriskfactoranalysisforintravenoustherapyinchildrenwithpreseptalorbitalcellulitis AT luisagalli optimizingantimicrobialroutesriskfactoranalysisforintravenoustherapyinchildrenwithpreseptalorbitalcellulitis AT elisabettaventurini optimizingantimicrobialroutesriskfactoranalysisforintravenoustherapyinchildrenwithpreseptalorbitalcellulitis |